Without treatment, mash can lead to conditions like cirrhosis and liver cancer. This will help you have a better understanding of your diagnosis and why your healthcare provider is recommending a particular course of treatment going forward *nash has been newly renamed metabolic dysfunction associated steatohepatitis or mash. Mash often is asymptomatic until its more advanced stages — which is exactly why early testing and diagnosis is critical to identifying and managing the condition, according to blanca c Get the facts on this severe form of fatty liver disease. This paper will review the key research advancements in the diagnosis and treatment of masld/mash over the past two decades, emphasizing the role of emerging technologies and diversified treatment strategies
The aim is to provide more accurate and individualized guidance for future clinical practice. Staging and monitoring fibrosis disease staging historically, mash has been diagnosed by liver biopsy Diagnosis of mash requires evidence of hepatic inflammation as well as steatosis, and requires biopsy showing histologic evidence of hepatocellular injury and inflammation with or without fibrosis (1, 2). It often develops due to a metabolic disorder, such as obesity or diabetes, resulting in a toxic buildup of fat in the liver
WATCH
